Federated Hermes Portfolio holdings
Federated Hermes is an investment manager that runs mutual funds, ETFs and other portfolios across stocks, bonds, alternative and private markets and liquidity management. It began in 1955 as Federated Investors, set up by three high school classmates: John F. Donahue, Thomas J. Donnelly and Richard B. Fisher. In 2018 the firm bought a majority stake in Hermes Fund Managers, which ran Hermes Investment Management, from the BT Pension Scheme. In 2020 Federated Investors renamed itself Federated Hermes. Its clients include corporations, government entities, insurance companies, foundations, endowments, banks and brokerages.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$436M |
| 2 |
Regions Financial
RF
|
+$313M |
| 3 |
Automatic Data Processing
ADP
|
+$289M |
| 4 |
Intuit
INTU
|
+$288M |
| 5 |
Netflix
NFLX
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$390M |
| 2 |
Teradyne
TER
|
+$320M |
| 3 |
Truist Financial
TFC
|
+$313M |
| 4 |
UnitedHealth
UNH
|
+$287M |
| 5 |
Huntington Bancshares
HBAN
|
+$215M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.03% |
| 2 | Healthcare | 13.59% |
| 3 | Industrials | 13.12% |
| 4 | Financials | 10.33% |
| 5 | Consumer Discretionary | 9.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
776
Arrowhead Research
ARWR
$8.46B
| $7.28M | 0.01% |
89,365
+75,253
| +533% | +$5.56M |
2025 Q3
3 quarters
|
|
777
Robert Half
RHI
$4.48B
| $7.28M | 0.01% |
237,247
+177,023
| +294% | +$4.96M |
2013 Q2
52 quarters
|
|
778
Alibaba
BABA
$244B
| $7.25M | 0.01% |
75,538
-308,406
| -80% | -$38.6M |
2014 Q3
47 quarters
|
|
779
Intapp
INTA
$3.24B
| $7.08M | 0.01% |
280,792
-32,945
| -11% | -$751K |
2023 Q1
13 quarters
|
|
780
Cal-Maine
CALM
$2.97B
| $7.04M | 0.01% |
87,386
-7,311
| -8% | -$564K |
2022 Q2
16 quarters
|
|
781
Emergent Biosolutions
EBS
$349M
| $6.96M | 0.01% |
831,125
+374,806
| +82% | +$3.14M |
2015 Q3
43 quarters
|
|
782
Travere Therapeutics
TVTX
$4.75B
| $6.93M | 0.01% |
122,015
+29,203
| +31% | +$1.29M |
2024 Q2
8 quarters
|
|
783
CEVA Inc
CEVA
$831M
| $6.89M | 0.01% |
146,061
-3,854
| -3% | -$136K |
2025 Q4
2 quarters
|
|
784
Hertz
HTZ
$684M
| $6.88M | 0.01% |
3,039,046
+2,509,005
| +473% | +$13.7M |
2024 Q3
7 quarters
|
|
785
VF Corp
VFC
$7.2B
| $6.87M | 0.01% |
411,646
-56,513
| -12% | -$1.01M |
2013 Q2
52 quarters
|
|
786
Bumble
BMBL
$800M
| $6.84M | 0.01% |
2,136,515
+441,886
| +26% | +$1.51M |
2025 Q1
5 quarters
|
|
787
Interface
TILE
$2.13B
| $6.77M | 0.01% |
188,842
-888
| -0.5% | -$25.9K |
2023 Q4
10 quarters
|
|
|
PBLS
788
Parabilis Medicines Inc
PBLS
$3.5B
| $6.74M | 0.01% |
+246,200
| New | +$6.8M |
2026 Q2
0 quarters
|
|
789
Everest Group
EG
$15.4B
| $6.71M | 0.01% |
18,783
+357
| +2% | +$122K |
2013 Q2
52 quarters
|
|
790
United Bankshares
UBSI
$6.57B
| $6.69M | 0.01% |
145,917
+76,252
| +109% | +$3.33M |
2017 Q2
36 quarters
|
|
791
Novavax
NVAX
$1.66B
| $6.62M | 0.01% |
703,006
+698,253
| +14,691% | +$6.26M |
2025 Q3
3 quarters
|
|
792
BrightView Holdings
BV
$1.09B
| $6.59M | 0.01% |
464,958
+5,303
| +1% | +$66.5K |
2023 Q2
12 quarters
|
|
793
Palisade Bio
PALI
$202M
| $6.56M | 0.01% |
3,136,607
| – | – |
2026 Q1
1 quarter
|
|
794
Aveanna Healthcare
AVAH
$2.87B
| $6.55M | 0.01% |
763,985
+2,914
| +0.4% | +$20.5K |
2023 Q4
10 quarters
|
|
795
Rigetti Computing
RGTI
$3.75B
| $6.46M | 0.01% |
334,333
+63,450
| +23% | +$1.23M |
2024 Q4
6 quarters
|
|
796
Itron
ITRI
$4.2B
| $6.36M | 0.01% |
73,448
+3,742
| +5% | +$319K |
2019 Q3
27 quarters
|
|
797
Domino's
DPZ
$10.3B
| $6.34M | 0.01% |
21,415
-103,764
| -83% | -$34.1M |
2013 Q2
52 quarters
|
|
798
ServisFirst Bancshares
SFBS
$4.4B
| $6.29M | 0.01% |
144,902
+1,742
| +1% | +$68.7K |
2024 Q4
6 quarters
|
|
799
Huron Consulting
HURN
$3.09B
| $6.27M | 0.01% |
69,490
-20,653
| -23% | -$2.37M |
2022 Q2
16 quarters
|
|
800
PVH
PVH
$4.16B
| $6.26M | 0.01% |
84,267
-61,341
| -42% | -$5.25M |
2013 Q2
52 quarters
|
|
Similar funds
Federated Hermes's Q2 2026 Portfolio in Review
As of Q2 2026, Federated Hermes held 2,221 positions worth $69.6B, up 13% from $61.5B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2026 filing shows 173 new, 863 increased, 913 reduced and 183 closed positions. Its largest new stake was AngloGold Ashanti: 2,040,755 shares worth $165M. The largest sale was Alphabet (Google) Class A, an estimated $390M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 22% a quarter earlier, followed by Healthcare and Industrials.
- Federated Hermes's largest Q2 2026 buy was AngloGold Ashanti: 2,040,755 shares worth $165M.
- Federated Hermes added most to Apple in Q2 2026, an estimated $436M increase.
- Federated Hermes's biggest Q2 2026 reduction was Alphabet (Google) Class A, cutting an estimated $390M.
- Federated Hermes fully exited Centessa Pharmaceuticals in Q2 2026, selling an estimated $81.4M.
- Federated Hermes's ten largest holdings make up 16% of its $69.6B portfolio in Q2 2026.
- Federated Hermes opened 173 new positions and closed 183 in Q2 2026.
- Federated Hermes's portfolio value rose 13% quarter-over-quarter to $69.6B.
Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.